Statement 26 May 2023

Individual statement at WHA76 on agenda items 13.1 and 13.2

On 26 May, IFPMA provided a WHA76 statement on agenda items 13.1: Reorienting health systems to primary health care as a resilient foundation for universal health coverage and preparations for a high-level meeting of the United Nations General Assembly on universal health coverage and 13.2: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, and mental health.

Statement 24 May 2023

Individual statement at WHA76 on agenda item 15.1

On 24 May, during the 76th World Health Assembly in Geneva, IFPMA delivered a statement on agenda item 15.1: Strengthening the global architecture for health emergency preparedness, response, and resilience.

Press release 22 May 2023

IFPMA and Speak Up Africa launch 2nd edition of flagship award program supporting young health innovators across Africa

IFPMA and Speak Up Africa launch the 2nd edition of the Africa Young Innovators for Health Award focused on supporting young health innovators across Africa advance their promising healthcare solutions in support of Universal Health Coverage. Four award winners will receive financial and in-kind support to bring their healthcare innovations to life. Dakar, Senegal and...

Infographic 22 May 2023

Advancing universal health coverage in Africa

Universal Health Coverage (UHC) is at the heart of the health-related Sustainable Development Goals (SDGs). It is the foundation for both global health security and the health and well-being of all people throughout their lifetimes. Africa’s health systems are essential in delivering the UHC2030 action agenda. Given Africa’s population is expected to double by 2050,...

Expert insight 20 May 2023

Clinical trials: Ethics, innovation, and how to achieve greater equity and equality

This blog was originally published on HYPER’s LinkedIn on 20 May 2023. This Clinical Trials Day, Mümün Gencoglu reflects on existing challenges to clinical trials diversity and how the role of ethics and scientific innovation can nurture a better research environment – not only today but for future generations. More information about this topic can...

Expert insight 19 May 2023

How Universal Health Coverage makes SDGs doable

This article was originally published on Re:solve Global Health, 19 May 2023. As an investment in our shared future of well-being, Universal Health Coverage promises to leave no one behind. But its implementation is fraught with challenges, especially in low- and middle-income countries. Universal Health Coverage (UHC) refers to the provision of health services and...

Position paper 15 May 2023

IFPMA Note for Guidance on sponsorship of events and meetings (2023 update)

Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.

Statement 9 May 2023

IFPMA statement at the Multi-stakeholder Hearing on Universal Health Coverage

On 9 May, IFPMA read the following statement at the Multi-stakeholder Hearing on Universal Health Coverage (UHC) in New York.

Statement 9 May 2023

IFPMA statement at the Multi-stakeholder Hearing on Pandemic Prevention, Preparedness, and Response

on 9 May, IFPMA read the following statement at the Multi-stakeholder Hearing on Pandemic Prevention, Preparedness, and Response in New York.

Statement 8 May 2023

IFPMA statement for Multi-stakeholder Hearing on Tuberculosis

On 8 may, IFPMA read the following statement at the Multi-stakeholder Hearing on Tuberculosis (TB) in New York.

Statement 5 May 2023

Comment on WHO announcement that COVID-19 no longer a Public Health Emergency of International Concern

IFPMA comment on WHO announcement that COVID-19 no longer constitutes a PHEIC.

Expert insight 2 May 2023

The power of partnerships and innovation: Accelerating progress toward Universal Health Coverage by 2030

In a blog for PharmaBoardroom, Thomas Cueni shares his views on the innovative pharmaceutical industry’s role in bringing critical solutions to accelerate progress toward UHC, from lab to the last mile.